Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 4/20 | 0.57 |
| ▸ | TLR2 | O60603 | 1/20 | 0.48 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.48 |
| ▸ | TLR6 | Q9Y2C9 | 1/20 | 0.48 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.45 |
| ▸ | TRIM24 | O15164 | 2/20 | 0.45 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30225047 | 1.00 | ERN1 (0.57) | ERN1TLR2TLR1TLR6SIRT2 | |
| SCHEMBL21002293 | 0.85 | ERN1 (0.59) | ERN1TLR2TLR1TLR6TRIM24 | |
| SCHEMBL8444934 | 0.85 | ERN1 (0.59) | ERN1TLR2TLR1TLR6TRIM24 | |
| SCHEMBL14354373 | 0.84 | ERN1 (0.53) | ERN1TLR2TLR1TLR6SIRT2 | |
| SCHEMBL29607733 | 0.83 | GABRA1 (0.64) | ERN1TLR2TLR1TLR6TRIM24 | |
| SCHEMBL1527079 | 0.83 | GABRA1 (0.64) | ERN1TLR2TLR1TLR6TRIM24 | |
| SCHEMBL22278289 | 0.82 | ERN1 (0.55) | ERN1TLR2TLR1TLR6TRIM24 | |
| SCHEMBL10824460 | 0.82 | ERN1 (0.55) | ERN1TLR2TLR1TLR6TRIM24 | |
| SCHEMBL30046638 | 0.82 | ERN1 (0.55) | ERN1TLR2TLR1TLR6TRIM24 | |
| SCHEMBL29141847 | 0.82 | ERN1 (0.57) | ERN1TLR2TLR1TLR6SIRT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1277793-C | Process for synthesizing 2-hydroxy-3-bromomethyl-5-substituted benzaldehyde | DALIAN CHEMICAL PHYSICS INST (CN) | 2006-10-04 | — | — | CN | claimed |
| CN-1634836-A | Process for synthesizing 2-hydroxy-3-bromomethyl-5-substituted benzaldehyde | DALIAN CHEMICAL PHYSICS INST (CN) | 2005-07-06 | — | — | CN | claimed |
| US-12215207-B2 | Method for producing a product reinforced by a reinforcing element | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2025-02-04 | — | — | US | disclosed |
| CN-115335201-B | Aqueous adhesive composition comprising a thermosetting resin with improved stability | 米其林集团总公司 | 2023-09-19 | — | — | CN | disclosed |
| EP-3487923-B1 | HIGH STRENGTH RUBBER COMPOSITION | MICHELIN & CIE (FR) | 2023-06-28 | — | — | EP | disclosed |
| US-11643579-B2 | Adhesive composition comprising a phosphate salt and a thermosetting resin | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2023-05-09 | — | — | US | disclosed |
| US-11624122-B2 | Process for electroplating an aqueous adhesive composition comprising a phosphate salt and a thermosetting resin on a conductive element | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2023-04-11 | — | — | US | disclosed |
| EP-4121266-A1 | AQUEOUS ADHESIVE COMPOSITION COMPRISING A THERMOSETTING RESIN WITH IMPROVED STABILITY | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2023-01-25 | — | — | EP | disclosed |
| CN-115335201-A | Aqueous adhesive composition comprising a thermosetting resin having improved stability | 米其林集团总公司 | 2022-11-11 | — | — | CN | disclosed |
| US-11485095-B2 | Composite and power transmission belt | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2022-11-01 | — | — | US | disclosed |
| US-11472946-B2 | High stiffness rubber composition | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2022-10-18 | — | — | US | disclosed |
| US-7205425-B2 | Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof | CHISSO CORPORATION (JP) | 2007-04-17 | — | — | US | disclosed |
| US-20070060656-A1 | Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof | SHIBASAKI MASAKATSU | 2007-03-15 | — | — | US | disclosed |
| CN-1277793-C | Process for synthesizing 2-hydroxy-3-bromomethyl-5-substituted benzaldehyde | DALIAN CHEMICAL PHYSICS INST (CN) | 2006-10-04 | — | — | CN | disclosed |
| US-20050148801-A1 | Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof | JNC CORPORATION (JP) | 2005-07-07 | — | — | US | disclosed |
| CN-1634836-A | Process for synthesizing 2-hydroxy-3-bromomethyl-5-substituted benzaldehyde | DALIAN CHEMICAL PHYSICS INST (CN) | 2005-07-06 | — | — | CN | disclosed |
| EP-0947498-B1 | OPTICALLY ACTIVE NITRO ALCOHOL DERIVATIVES, OPTICALLY ACTIVE AMINO ALCOHOL DERIVATIVES, AND PROCESS FOR PREPARING THE SAME | CHISSO CORP (JP) | 2004-09-15 | — | — | EP | disclosed |
| US-6632955-B1 | Optically active 1-substituted phenyl-2-nitro alcohol derivatives which are useful pharmaceutical intermediates. Enantiomotphs active 1-substituted phenyl-2-nitro alcohol derivatives. From these nitro alcohol such as albutramin and | CHISSO CORPORATION (JP) | 2003-10-14 | — | — | US | disclosed |
| US-20020193447-A1 | Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof | JNC CORPORATION (JP) | 2002-12-19 | — | — | US | disclosed |
| EP-0947498-A1 | OPTICALLY ACTIVE NITRO ALCOHOL DERIVATIVES, OPTICALLY ACTIVE AMINO ALCOHOL DERIVATES, AND PROCESS FOR PREPARING THE SAME | CHISSO CORPORATION (JP) | 1999-10-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050148801-A1 | Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof | ADH1A, ALDH7A1, ADRB1 | ERN1 2031/4885TLR2 3341/4885TLR1 1256/4885 |
| US-20070060656-A1 | Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof | ADH1A, ALDH7A1, ADRB1 | ERN1 2031/4885TLR2 3341/4885TLR1 1256/4885 |
| US-20020193447-A1 | Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof | ADH1A, ALDH7A1, SARM1 | ERN1 2019/4885TLR2 2855/4885TLR1 913/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.